A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells

Recent advances in the generation of cardiomyocytes (CMs) from human pluripotent stem cells (hPSCs), in conjunction with the promising outcomes from preclinical and clinical studies, have raised new hopes for cardiac cell therapy. We report the development of a scalable, robust, and integrated diffe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cells Transl Med
Main Authors: Fonoudi, Hananeh, Ansari, Hassan, Abbasalizadeh, Saeed, Larijani, Mehran Rezaei, Kiani, Sahar, Hashemizadeh, Shiva, Zarchi, Ali Sharifi, Bosman, Alexis, Blue, Gillian M., Pahlavan, Sara, Perry, Matthew, Orr, Yishay, Mayorchak, Yaroslav, Vandenberg, Jamie, Talkhabi, Mahmood, Winlaw, David S., Harvey, Richard P., Aghdami, Nasser, Baharvand, Hossein
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2015
Assuntos:
Protocols and Manufacturing for Cell-Based Therapies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4675501/
https://ncbi.nlm.nih.gov/pubmed/26511653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2014-0275
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados